Loading...
The future of drug eluting stents
In‐stent restenosis (ISR) is the major drawback of percutaneous coronary interventions, occurring in 10–40% of patients. Drug eluting stents (DES) are successful in a large majority of patients in preventing restenosis for the first year after implantation. Recently, new stents have emerged that are...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Group
2006
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1860903/ https://ncbi.nlm.nih.gov/pubmed/16216857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2005.068288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|